biosurgery


Also found in: Dictionary.
Orthopedics An emerging field that utilizes enabling biomaterial, therapeutic, and sophisticated device technologies to improve the health of patients in the orthopedics and post-surgical adhesive disease areas
Wound care Maggot debridement therapy

biosurgery

The use of live sterile maggots to clean up and disinfect infected wounds.
References in periodicals archive ?
The global biosurgery market is expected to reach USD 12.
Global Biosurgery Market to Reach USD 12.5bn by 2021, Research and Markets Forecasts
The world biosurgery market is projected to grow at a substantial rate owing to rise in sport & spine-related injuries, per capita healthcare expenditure, rise in number of surgeries due to increase in obese population along with lifestyle disorders and others.
Biosurgery Market is Expected to Reach $12.7 Billion by 2022
Stony Brook University Hospital intends to purchase Baxter Biosurgery Gelfoam and related items under Novation contract # RX 90040 dated 1/1/2009 - 12/31/2016 from a contract awarded pursuant to their authority under section 163(3)(vi), which authorizes the purchase of commodities from a consortium or comparable entity in lieu of using a centralized contract and without a formal competitive process when justified by price.
Provision Of Biosurgery Gelfoam
Kuros Biosciences Ltd (Kuros) (SIX:KURN) revealed on Wednesday that it has completed the acquisition of Kuros Biosurgery Holding Ltd.
Kuros Biosurgery Holding merges with and into Kuros Biosurgery Holding Ltd
This report provides comprehensive information on the current therapeutic developmental pipeline of Kuros Biosurgery AG's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.
Kuros Biosurgery AG - Product Pipeline Review - 2015 - New Market Research Report
I know Ethicon Biosurgery and IDA have worked hard to get to this point and I wish the company every success with this project.
420 JOBS CREATED AT MEDICAL DEVICE FIRM; Company's [euro]80m plant investment 'major coup'
This report is built using data and information sourced from Global Markets Direct's proprietary databases, Kuros Biosurgery AG's corporate website, SEC filings, investor presentations and featured press releases, both from Kuros Biosurgery AG and industry-specific third party sources, put together by Global Markets Direct's team.
Market Report, "Kuros Biosurgery AG - Product Pipeline Review - 2013", published
The acquisition of Pluromed underscores Sanofi's commitment to strengthen its Biosurgery portfolio," said Alison Lawton, senior vice president and general manager of Sanofi's Biosurgery business.
Serious deal for a product with a funny name
The deal will significantly increase Strykera[euro](tm)s orthobiologics product portfolio and enhance its position in the spine, orthopaedics and biosurgery sectors, the buyer said in a press release.
Stryker finalises Orthovita takeover
This collaboration is a great strategic fit for Genzyme Biosurgery, and we are extremely excited to be working with two leaders in the understanding of the root causes of cardiac arrhythmias, and the potential for gene therapy to address them," said Duke Collier, president of Genzyme Biosurgery.
Genzyme Biosurgery, Excigen collaborate in developing gene therapy for cardiac arrhythmia
Gyrus ENT LLC (formerly Smith & Nephew ENT and Somnus[R]) and Genzyme Biosurgery, a division of Genzyme Corporation, have entered into an exclusive 5-year agreement for the distribution of several of Genzyme's Sepra[TM] products for use in ENT procedures.
Nasal-packing products. (Product Marketplace)
NASDAQ: VITA), an orthobiologics and biosurgery company, announced today that it will present at the Bank of America Merrill Lynch Health Care Conference in Las Vegas.
Orthovita to Present at the Bank of America Merrill Lynch Health Care Conference
Medical browser ?
Full browser ?